PUBLICATIONS

1. The role of the chronic care model in promoting the management of the patient with rare liver disease. Pericleous M, Kelly C, Ala A, de Lusignan S. Expert Rev Gastroenterol Hepatol. 2018 Jul 5. doi: 10.1080/17474124.2018.1497483. [Epub ahead of print] Original Research

2. Interventions to improve the uptake of screening across a range of conditions in Ethnic Minority Groups: a systematic review. Kelly C, Pericleous M, Hendy J, de Lusignan S, Ahmed A, Vandrevala T, Ala A. Int J Clin Pract. 2018 Jun 19:e13202. doi: 10.1111/ijcp.13202. [Epub ahead of print] Review.

3. Pregnancy-Associated liver disease: A curriculum based review. Pericleous M, Kelly C (joint first authorship. Frontline Gastroenterol. 2018 Jul;9(3):170-174

4. Wilson Disease: More Than Meets the Eye, Pericleous M, Kelly C (joint first authorship),Postgrad Med J. 2018 Jun;94(1112):335-3472.

5. The clinical management of hereditary haemochromatosis, Pericleous M, Kelly C (joint first authorship) Frontline Gastroenterol. 2018 Apr;9(2):110-114.

6. Wolman’s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Pericleous M, Kelly C, Wang T, Livingstone C, Ala A. Lancet Gastroenterol Hepatol. 2017 Sep;2(9):670-679. doi: 10.1016/S2468-1253(17)30052-3.

7. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M. Eur J Gastroenterol Hepatol.  2016 Mar;28(3):e10-8. 

8. Outcomes of Hepatic artery embolisation in patients with  neuroendocrine tumours Pericleous M, Caplin ME, Tsochatzis E, Yu D, Morgan-Rowe L, Toumpanakis C. Asia Pac J Clin Oncol. 2016 Mar;12(1):61-9. doi: 10.1111/ajco.12438.

9. Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients. Pericleous M, Karpathakis A, Lumgair H, Reiner J, Toumpanakis C, Marelli L, Thirlwell C, Meyer T, Caplin ME.  Clin Respir J. 2016 Dec 27. doi: 10.1111/crj.12603.

10. Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumour. Karpathakis A, Dibra H, Pipinikas C, Feber A, Morris T, Francis JM, Oukrif D, Mandair D, Pericleous M, Mohmaduvesh M, Serra S, Ogunbiyi O, Novelli M, Luong T, Asa SL, Kulke MH, Toumpanakis C, Meyer T, Caplin M, Meyerson M, Beck S, Thirlwell C. ; Clin Cancer Res. 2015 Jul 13

11. Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases. Karpathakis A, Dibra H, Pipinikas C, Feber A, Morris T, Francis J, Oukrif D, Mandair D, Pericleous M, Mohmaduvesh M, Serra S, Ogunbiyi O, Novelli M, Luong T, Asa SL, Kulke M, Toumpanakis C, Meyer T, Caplin M, Beck S, Thirlwell C.

12. Endocr Relat Cancer. 2017 Feb;24(2):L21-L25. doi: 10.1530/ERC-16-0419. No abstract available.

13. The Management of Acute Upper Gastrointestinal Bleeding; a Comparison of Current Clinical Guidelines and Best Practice Taylor A, Redfern O, Pericleous M;  EMJ Gastroenterol. 2014;2 

14. Outcomes Of Increased Dose Of Allopurinol In IBD Patients Who Developed Hepatotoxicity On Low Azathioprine And Allopurinol Co-therapy Treatment. Pericleous M, Abdulrehman A, Bull C, Mackenzie G, Stenner J, Cowan M, Hillman G, Ansari A. Gut. 2014 Jun;63 Suppl 1:A84-5. doi: 10.1136/gutjnl-2014-307263.178.

15. Prostate cancer and the influence of dietary factors and supplements: a systematic review.mMandair D, Rossi RE, Pericleous M, Whyand T, Caplin ME. Nutr Metab (Lond). 2014 Jun 16;11:30. doi: 10.1186/1743-7075-11-30. eCollection 2014. Review.

16. The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma. Mandair DS, Rossi RE, Pericleous M, Whyand T, Caplin M. Expert Rev Gastroenterol Hepatol. 2014 May;8(4):369-82. doi: 10.1586/17474124.2014.894879. Epub 2014 Mar 6.

17. Nutrition and pancreatic cancer. Pericleous M, Rossi RE, Mandair D, Whyand T, Caplin ME. Anticancer Res. 2014 Jan;34(1):9-21.

18. Diet and supplements and their impact on colorectal cancer.  Pericleous M, Mandair D, Caplin ME; J Gastrointest Oncol. 2013 Dec;4(4):409-23. 

19. Using an “action set’ for the management of acute upper gastrointestinal bleeding Pericleous M, Murray C, Hamilton M, Epstein O, Negus R, Peachey T, Kaul A, O'Beirne J.  Therap Adv Gastroenterol. 2013 Nov;6(6):426-37. 

20. Pancreatic adenocarcinoma in a patient with multiple endocrine neoplasia 1 syndrome. Karpathakis A, Pericleous M, Luong TV, Khoo B, Thirlwell C, Toumpanakis C, Caplin ME;  Pancreas. 2013 May; 42(4):725-6. 

21. Appendiceal goblet cell carcinoid tumour: a case of unexpected lung metastasis. Pericleous M, Lumgair H, Baneke A, Morgan-Rowe L, E Caplin M, Luong TV, Thirlwell C, Gillmore R, Toumpanakis C;  Case Rep Oncol. 2012 May;5(2):332-8

22. Gastric mixed adenoneuroendocrine carcinoma with a trilineage cell differentiation: case report and review of the literature. Pericleous M, Toumpanakis C, Lumgair H, Caplin ME, Morgan-Rowe L, Clark I, Luong TV; 

23. Case Rep Oncol. 2012 May;5(2):313-9.

24. Hepatobiliary disease associated with hypereosinophilia: a report of two patients and a review of the literature. Morgan-Rowe LM, Pericleous M, Luong TV, Dooley JS, Burroughs AK.  Dig Dis Sci. 2011 Dec;56(12):3689-94

SCIENTIFIC MEETINGS

• Regional Surrey meeting for rare liver diseases; Guildford; October 2017 

• BASL international meeting 2017; Coventry; September 2017 

• SESAM (Society in Europe for Simulation Applied to Medicine); Paris, June 2017

• BSG international meeting 2017; Manchester; June 2017

• AASLD international meeting; Boston; November 2016

• Viral Hepatitis; State of the Art Review; London, November 2016

• Falk Symposium 205 “New Treatment Targets in Gut and Liver Disease”; Switzerland, October 2016

• BASL (British Association for the Study of the liver) annual national meeting; Manchester; September 2016 

• Regional Surrey meeting for rare liver diseases; Guildford; September 2016 

• Falk Symposium 204 “Clinical Hepatology Practice in 2016: from Science to Therapy; Birmingham; September 2016

• Falk Symposium “Autoimmune disease of the liver”; Lisbon, May 2015 

• St George’s Gastroenterology training day; London, March 2015 

• BVHG Meeting ‘Newer HCV Regimens – Why, how, when.....’; London, March 2015  

• Portsmouth Advanced Endoscopy Symposium; Portsmouth, January 2015

• IBS Road Show symposium; London, November 2014 

• Frontiers in Hepatology; London, The institute of Hepatology, October 2014

• Complex Gastroenterology; Maidstone, October 2014

• Internal Medicine Research and Audit Day (IMRAD); Brighton, September 2014

• National BSG Meeting 2013 Glasgow; June 2013

• National BSG-DDF Meeting; Liverpool; June 2012

• 9th European ENETS conference, Copenhagen; March 2012

• 9th National UKINETS conference, London; November 2011   

• Regional Update in Medicine; Royal Free hospital; November 2011

• Endocrinology investigations; Royal Society of Medicine; May 2011

• IBD for trainees; Royal Society of Medicine; February 2011

• Hepatology for the trainees; Royal Society of Medicine; October 2010

• Acute and general Medicine for the Physician; 3-day course at the Royal College of Physicians; October 2010

AUDIT & CLINICAL GOVERNANCE

• Replacing electrolytes in inpatients; auditing junior doctors and development of pocket guidelines; Frimley Park Hospital NHS Foundation Trust

• PEG tubes and emergency presentations in A&E; Frimley Park Hospital NHS Foundation Trust

• Recording of OGD indications, risk scores, endoscopic findings and endotherapy delivered in UniSoft; East Surrey & Sussex Healthcare NHS Trust; August 2014  

• Waiting times from admission and diagnosis to endoscopy in patient with upper GI bleeding; East Surrey & Sussex Healthcare NHS Trust; July 2014

• MUST scoring and nutrition screening on the medical wards; Brighton and Sussex University Hospitals NHS Trust; August 2013

• Acute management of Upper GI bleeding and the bleeding proforma. Royal Free Hampstead NHS Trust; May 2010

• Rebleed after endotherapy. Hemel Hempstead General Hospital; February 2009

• Rebleeding rates and types IV PPI administered. Hemel Hempstead General Hospital; February 2009

• Performing peripheral blood cultures Royal Free Hampstead NHS Trust; January 2008

• Down’s syndrome screening awareness in the ethnic minorities. North Middlesex Hospital; September 2006      

• The effectiveness and usefulness of mnemonics in clinical teaching. University College London; September 2006.

BOOK CHAPTERS

1. The epidemiology of rare hereditary metabolic liver diseases in “Clinical Epidemiology of Chronic Liver Disease”. Publisher: Springer Nature; Pericleous M, Kelly C, Ala A, Schilsky M.

2. Diagnosis confirmation and screening of Wilson disease in “Management of Wilson Disease: A Pocket Guide”. Pericleous M, Kelly C, Schilsky M.

3. Treatment options for Wilson disease in “Management of Wilson Disease: A Pocket Guide”. Kelly C, Pericleous M, Schilsky M.

PRESENTATIONS: ORAL, POSTER & LECTURES

• Oral: Regional Surrey meeting on autoimmune liver diseases; Guildford; October 2017 

• Poster: Is the chronic care model the answer to the unmet need for integrated care in orphan liver diseases? BASL meeting; Coventry, 2017

• Poster: Interpretation of low lysosomal acid lipase (LAL) levels in the hepatology and metabolic services; BASL meeting; Coventry, 2017

• Poster: Primary Biliary Cholangitis (PBC) - a neglected disease in primary care? BASL meeting; Coventry, 2017

• Poster: The chronic care model (CCM) in primary biliary cholangitis (PBC): Time to reconsider our approach; BASL meeting; Coventry, 2017

• Oral presentation: “A novel approach to simulation training for foundation year doctors; embracing new technologies and applying learning theory”; Society in Europe for Simulation Applied to Medicine (SESAM) meeting; Paris, June 2017

• Poster: What is the meaning of low lysosomal acid lipase (LAL) levels in the hepatology and metabolic clinic? ; BSG national meeting; Manchester, 2017

• Poster: Regional and national understanding of IgG-related disease (IgG4-RD) in the UK: Strategic implications in testing and case-finding; American Association for the study of the liver (AASLD) annual meeting; Boston; November 2016 

• Poster: Experience of IgG4-related disease (IgG4-RD) in the UK: an online national survey; DrFalk symposium “New Treatment Targets in Gut and Liver Disease”; Switzerland, October 2016

• Poster: Trends of serum IgG4 level testing in a UK tertiary hepatopancreatobiliary (HPB) centre and correlation with the diagnosis of IgG4-related disease (IgG4-RD); DrFalk symposium “New Treatment Targets in Gut and Liver Disease”; Switzerland, October 2016

• Lecture: LAL deficiency and other rare diseases; Regional Surrey meeting for rare liver diseases; Guildford; September 2016 

• Lecture: The management of ascites in palliative care: 5th Guildford Advanced Pain & Symptom Management Course of the society of palliative medicine; Guildford; September 2016 

• Poster: The role of repeat liver biopsy in autoimmune hepatitis (AIH) in a tertiary HPB centre in South east England: current experience, clinical dilemmas and recommendations; British Association for the Study of the liver (BASL) annual meeting; Manchester; September 2016 

• Poster: Regional and National understanding of IgG-related disease (IgG4-RD) in the United Kingdom: patterns of testing, case-finding and areas for development; British Association for the Study of the liver (BASL) annual meeting; Manchester; September 2016

• Oral presentation: Regional Training Research Networks; National BSG meeting; Liverpool 2016 

• Lecture: The management of ascites and SBP; Geriatric regional training day for KSS trainees; Frimley Park Hospital; July 2015

• Oral presentation: Replacing electrolytes in inpatients: experience from a district general hospital; Buckinghamshire Foundation Forum; Stoke Mandeville; June 2015

• Lecture: Grand Round: Evidence-based management of ascites; Frimley Park hospital; May 2015 

• Poster: DrFalk Symposium 2015 on Autoimmune liver disease: Hypereosinophilic Autoimmune liver disease: A report of three unusual cases; Lisbon; May 2015 

• Poster: LDAA and hepatotoxicity in IBD patients; BSG national meeting; Manchester; June 2014

• Lecture: Grand Round: 1) NETs 2) Management of ascites; East Surrey Hospital; March 2014

• Poster: TAE Vs TACE; BSG national meeting; Glasgow, 2013

• Weekly Neuroendocrine MDT preparation and presentation; Royal Free Hospital; August 2011- September 2012

• Poster: Diagnostic and therapeutic outcomes in goblet cell appendiceal neuroendocrine tumours; National DDF & BSG joint conference 2012:  Liverpool; June 2012

• Poster: Epidemiology and management outcomes in bronchial neuroendocrine tumours: a clinical study of 116 patients;9th European ENETS conference; Copenhagen; March 2012

• Poster: 9th National UKINETS conference; London, November 2011

• Lecture: Oncology meeting of the Royal Free Hospital: “The patient journey”:  Presenting the results of my GI oncology audit; June 2011      

• Lecture: Cardiology Clinical Governance meeting: Morbidity & Mortality; Royal Free Hospital; June 2011      

• Poster: There will be blood....a complete audit cycle; National BSG conference 2011 meeting, Birmingham; March 2011

• Poster: There will be blood; 4th International Conference of the Society of Acute Medicine (SAM): Edinburgh; October 2010

• Lecture: Grand Round presentation: “There will be blood”, Royal Free Hospital; September 2010

• Lecture: Clinical Governance meeting for acute medicine. Presentation of my audit on the management of upper GI bleeding; Royal Free Hospital; May 2010

• Lecture: Weekly case study presentations at the morning report; Royal Free Hospital August 2009- February 2010

• Lecture: Clinical governance meeting for gastroenterology:  Presentation of my “Re-bleed after endotherapy” audit; Hemel Hempstead General Hospital; February 2009 

• Lecture: Department of geriatrics medical meeting: Presented two times on the management of Multiple Myeloma and the pathophysiology of jaundice; Hemel Hempstead General Hospital; August 2008- December 2008:

• Oral presentation:  Is the incidence of breast cancer among Asian women living in the UK, higher at a younger age than in Caucasian women? 30th Annual International San Antonio Breast Cancer Symposium; San Antonio, Texas, USA; December 2008:

• Lecture: Weekly Oncology and breast surgery MDT meeting: weekly preparation and presentation of meeting; Royal Free Hampstead NHS Trust; March 2008- July 2008:                      

• Lecture: Morbidity & Mortality meeting; department of surgery: monthly presentations; Royal Free Hampstead NHS Trust; March-July 2008

• Lecture: Morbidity & Mortality meeting; department of cardiology: monthly presentations; Royal Free Hampstead NHS Trust; January 2008 –March 2008

• Lecture: Audit presentation: “Taking peripheral blood cultures”; Presented to the staff of MAAU, leading consultants in infection control and the board of trustees; Royal Free Hampstead NHS Trust; August 2008.